PARTNERING

Collaborating to bring durable cell
therapy to solid tumor patients

Partner with Us

ImmunoScape offers partnering opportunities centered on our transformative Seed-and-Boost approach. The flexibility of our platform technology enables the development of superior T cell therapies—independent of target, patient background, or cell modality.

Our T-cell engagers are designed to selectively activate and expand tumor-specific T cells, with the potential to enhance both existing and emerging cancer immunotherapies, including CAR-T and TCR-T cell therapies and cancer vaccines. We partner with therapeutic companies to unlock the potential of these therapies.

Together, we can deliver next-generation T cell therapies to address the high unmet needs of patients with cancer.

Please contact us to explore innovative partnering models and value creation opportunities.